Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07096037 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Safety and Efficacy of Urtica Dioica Cataplasm in the Management of Osgood-Schlatter Disease in Young Athletes

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 1, 2025 (before its estimated September 15, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Interventions: Placebo (Other), Urtica dioica cataplasm (Other), vitamin D + rest (Drug) to Placebo (Other), Resting conditions (Behavioral), Urtica dioica cataplasm (Other), Vitamin D (Drug)v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The primary objective of this clinical trial is to evaluate the efficacy and safety of a topical Urtica dioica cataplasm in managing knee pain and functional limitations in athletic children diagnosed with Osgood-Schlatter Disease. Efficacy will be assessed through changes in knee pain using the Visual Analog Scale (VAS) and functional outcomes using the Knee Injury and Osteoarthritis Outcome Score (KOOS). Three groups will be tested: * UDC Group: topical application of Urtica dioica cataplasm * Standard Care Group: oral vitamin D supplementation and physical rest * Placebo Group: topical application of a placebo cataplasm using Beta vulgaris subsp. cicla
Trial Details
NCT Number NCT07096037
Lead Sponsor Faculty of Medicine, Sousse
Conditions
(from sponsor)		 Osgood-Schlatter Disease
Related terms Osteochondrosis
Enrollment 90 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov